Status: Open Not Enrolling
Investigator: Orlando Diaz
Study Coordinator:
Phone:
The primary objective of this study is to demonstrate effectiveness and safety of the NeuroForm Atlas stent system for use with bare metal embolic coils ... Read more >
Status: Enrolling
Investigator: Vivek Misra
Study Coordinator: Charles McCane
Phone: 713.441.5801
ARCADIA is a multicenter, biomarker-driven, randomized, double-blind, active-control, phase 3 clinical trial of apixaban versus aspirin in patients who have evidence of atrial cardiopathy and a recent stroke of unknown cause. Eleven hundred subj ... Read more >
Status: Enrolling
Investigator: David Chiu
Study Coordinator:
Phone:
Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asym ... Read more >
Status: Enrolling
Investigator: Vivek Misra
Study Coordinator:
Phone:
he primary efficacy objective of the MOST trial is to determine if argatroban (100µg/kg bolus followed by 3µg/kg per minute for 12 hours) or eptifibatide (135µg/kg bolus followed by 0.75µg/kg/min infusion for two hours) results in improved 90-da ... Read more >
Status: Enrolling
Investigator: David Chiu
Study Coordinator:
Phone:
A Phase 3 study to examine the safety and effectiveness of the allogeneic, adult stem cell investigational product, MultiStem, in adults who have suffered an acute ischemic stroke in the previous 18-36 hours. ... Read more >
